Meditrina, founded in 2016 and based in San Jose, California, designs and develops the Aveta™ System for the treatment of intrauterine pathologies such as polyps, fibroids, and RPOC. The company completed a $10m equity financing, which represents the first tranche of a $20m commercialization round. The round was led by Deerfield Management Company; Deerfield Partner Steven Hochberg will join Meditrina's Board of Directors in conjunction with the funding. Meditrina intends to use the proceeds to expand U.S. commercialization of the Aveta System and to further develop its product portfolio. Csaba Truckai, the company's founder, serves as President and CEO. Meditrina, Inc. is a San Jose, CA-based women’s healthcare company and developer of the Aveta™ System for treatment of intrauterine pathologies such as polyps and fibroids. The Aveta System is intended for hysteroscopic tissue chip resection under continuous flow using a proprietary expandable working channel hysteroscope combined with a fluid management and resection system. The system is designed so the physician can control all procedure parameters and view the procedure on a single monitor. The Aveta System received U.S. FDA 510(k) clearance in May 2019. Meditrina completed a $13M equity financing and intends to use the proceeds to launch U.S. commercialization of the Aveta System. The company is led by President and CEO Csaba Truckai, and concurrent with the financing William Dai of ShangBay Capital will join the Meditrina Board of Directors. Meditrina is a pre-FDA cleared medical device company based in Cupertino, CA, founded in 2016 by Csaba Truckai. The company is developing fully disposable endoscopes and an office-based platform targeted at gynecologists. Its first system, Aveta, is intended for hysteroscopic diagnostic and therapeutic uterine procedures, including removal of polyps and fibroids. Meditrina plans to use financing proceeds to further develop and to accelerate commercial activities for the Aveta system. The company received a $5M venture loan facility from Horizon Technology Finance, with $3M initially funded. Horizon is a specialty finance company that provides secured loans to venture-backed technology and life-science firms.

Total raised

$28M

Funding rounds

3

Latest round

Equity

Latest activity

Jun 2020